Together in collaboration with National University Hospital of Singapore (NUH) and National University of Singapore (NUS), Helios is developing a high speed DNA sequencing tool . Faculty members and doctors from molecular diagnostic center, medicine, biological sciences and physics are working together to perform clinical validation of high speed genomic screening tool to identify leukemia and breast cancer sub-type for treatment.
Integrated with Helios AI and high speed imaging capabilities the tool will be able to accurately sequence the DNA and quickly provide an analysis to aid oncologist in preparing a treatment plan for patient undergoing immunotherapy.
White Paper: Nanofluidic screening of genomic structural variations